GFM

GF Fund Management Portfolio holdings

AUM $4.97B
This Quarter Return
+21.29%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$57.6M
Cap. Flow %
1.16%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Sector Composition

1 Technology 46.23%
2 Consumer Discretionary 14.24%
3 Communication Services 13.85%
4 Consumer Staples 7.1%
5 Healthcare 7.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GLUE icon
601
Monte Rosa Therapeutics
GLUE
$305M
$7.09K ﹤0.01%
1,572
ALT icon
602
Altimmune
ALT
$334M
$7.05K ﹤0.01%
1,821
VNDA icon
603
Vanda Pharmaceuticals
VNDA
$272M
$7.05K ﹤0.01%
1,493
CBL
604
CBL Properties
CBL
$990M
$6.93K ﹤0.01%
273
+42
+18% +$1.07K
HUMA icon
605
Humacyte
HUMA
$226M
$6.89K ﹤0.01%
3,295
SLN
606
Silence Therapeutics
SLN
$269M
$6.76K ﹤0.01%
1,165
RNAC icon
607
Cartesian Therapeutics
RNAC
$277M
$6.75K ﹤0.01%
650
TKNO icon
608
Alpha Teknova
TKNO
$233M
$6.7K ﹤0.01%
1,365
FHTX icon
609
Foghorn Therapeutics
FHTX
$326M
$6.69K ﹤0.01%
1,424
ANNX icon
610
Annexon
ANNX
$238M
$6.55K ﹤0.01%
2,729
TRDA icon
611
Entrada Therapeutics
TRDA
$201M
$6.44K ﹤0.01%
958
CRVS icon
612
Corvus Pharmaceuticals
CRVS
$459M
$6.38K ﹤0.01%
1,594
INZY
613
DELISTED
Inozyme Pharma
INZY
$6.18K ﹤0.01%
1,544
THRD
614
DELISTED
Third Harmonic Bio
THRD
$6.07K ﹤0.01%
1,118
ALLO icon
615
Allogene Therapeutics
ALLO
$255M
$6.07K ﹤0.01%
5,368
OLMA icon
616
Olema Pharmaceuticals
OLMA
$570M
$6.06K ﹤0.01%
1,422
ETR icon
617
Entergy
ETR
$39.2B
$5.99K ﹤0.01%
72
-8,939
-99% -$743K
MXCT icon
618
MaxCyte
MXCT
$150M
$5.89K ﹤0.01%
2,701
RCKT icon
619
Rocket Pharmaceuticals
RCKT
$354M
$5.72K ﹤0.01%
2,333
NGNE icon
620
Neurogene
NGNE
$285M
$5.5K ﹤0.01%
368
OABI icon
621
OmniAb
OABI
$246M
$5.39K ﹤0.01%
3,099
TVGN icon
622
Tevogen Bio Holdings
TVGN
$170M
$5.26K ﹤0.01%
4,207
INBX icon
623
Inhibrx
INBX
$408M
$5.12K ﹤0.01%
359
YMAB icon
624
Y-mAbs Therapeutics
YMAB
$390M
$5.01K ﹤0.01%
1,111
ACIU icon
625
AC Immune
ACIU
$229M
$4.98K ﹤0.01%
2,454